Start-Up Quarterly Statistics, Q1 2016

Life science start-up companies raised a total of $1.8 billion in the first quarter of 2016, $579 million less than the previous quarter. Thirty-seven biopharma companies combined for $1.3 billion, with 17 of those firms together bringing in $508.5 million in Series A funding. Three medical device firms raised a total of $59.4 million during Q1. Ten in vitro diagnostics start-ups pulled in $431.3 million. Diagnostics was the only industry that saw an increase in fundraising compared with the previous quarter ($45.2 million). (See Exhibit 1.)